First Time Loading...

Arcutis Biotherapeutics Inc
NASDAQ:ARQT

Watchlist Manager
Arcutis Biotherapeutics Inc Logo
Arcutis Biotherapeutics Inc
NASDAQ:ARQT
Watchlist
Price: 7.99 USD 0.5%
Updated: May 7, 2024
Section:
 

Wall Street
Price Targets

ARQT Price Targets Summary
Arcutis Biotherapeutics Inc

Wall Street analysts forecast ARQT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ARQT is 18.36 USD with a low forecast of 11.11 USD and a high forecast of 27.3 USD.

ARQT Lowest Forecast
Wall Street Target
11.11 USD
39% Upside
ARQT Average Forecast
Wall Street Target
18.36 USD
130% Upside
ARQT Highest Forecast
Wall Street Target
27.3 USD
242% Upside
Lowest
Price Target
11.11 USD
39% Upside
Average
Price Target
18.36 USD
130% Upside
Highest
Price Target
27.3 USD
242% Upside

ARQT Last Price Targets
Arcutis Biotherapeutics Inc

The latest public price target was made on Jan 2, 2024 by Unknown Analyst from Mizuho Securities , who expects ARQT stock to rise by 0% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Unknown Analyst
Mizuho Securities
8 USD
Upside 0%
4 months ago
Jan 2, 2024
Arcutis Biotherapeutics Inc. (ARQT) PT Raised to $8 at Mizuho Securities, Upgraded to Buy
StreetInsider
Unknown Analyst
Mizuho Securities
Price Target 8 USD
Upside/Downside 0%
View Source
Arcutis Biotherapeutics Inc Competitors:
Price Targets
ORGO
Organogenesis Holdings Inc
106% Upside
6160
Beigene Ltd
40% Upside
I
086890
Isu Abxis Co Ltd
111% Upside
ARWR
Arrowhead Pharmaceuticals Inc
126% Upside
ORGO
Organogenesis Holdings Inc
106% Upside
6160
Beigene Ltd
40% Upside
I
086890
Isu Abxis Co Ltd
111% Upside
ARWR
Arrowhead Pharmaceuticals Inc
126% Upside
XBIT
XBiotech Inc
92% Upside
RARE
Ultragenyx Pharmaceutical Inc
112% Upside
TRDA
Entrada Therapeutics Inc
59% Upside
APLT
Applied Therapeutics Inc
147% Upside

Revenue
Forecast

Revenue Estimate
Arcutis Biotherapeutics Inc

The compound annual growth rate of Arcutis Biotherapeutics Inc's revenue for the next 3 years is 84%.

N/A
Past Growth
84%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Arcutis Biotherapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Arcutis Biotherapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-58%
Average Miss
What are analyst estimates?

See Also

Summary
ARQT intrinsic value, competitors valuation, and company profile.
DCF Valuation
ARQT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ARQT stock valuation using valuation multiples.
Wall Street Estimates
ARQT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ARQT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ARQT's stock price target?
Price Target
18.36 USD

According to Wall Street analysts, the average 1-year price target for ARQT is 18.36 USD with a low forecast of 11.11 USD and a high forecast of 27.3 USD.

What is Arcutis Biotherapeutics Inc's Revenue forecast?
Projected CAGR
84%

The compound annual growth rate of Arcutis Biotherapeutics Inc's revenue for the next 3 years is 84%.

ALPHA SPREAD
Join more than 135,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.